153 related articles for article (PubMed ID: 16255668)
1. Atypical antipsychotic drugs, diabetes and ethnicity.
Ananth J; Kolli S; Gunatilake S; Brown S
Expert Opin Drug Saf; 2005 Nov; 4(6):1111-24. PubMed ID: 16255668
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
3. Abnormal glucose metabolism in patients treated with antipsychotics.
Scheen AJ; De Hert MA
Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing DA
J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
6. [Atypical antipsychotic induced weight gain and metabolic disorders].
Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
[TBL] [Abstract][Full Text] [Related]
7. Weighing in: emergent diabetes mellitus and second-generation antipsychotics.
Dufresne RL
Ann Pharmacother; 2007 Oct; 41(10):1725-7. PubMed ID: 17785611
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
9. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of atypical antipsychotics.
Wirshing DA
J Clin Psychiatry; 2001; 62 Suppl 21():7-10. PubMed ID: 11584988
[TBL] [Abstract][Full Text] [Related]
11. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
12. Consensus development conference on antipsychotic drugs and obesity and diabetes.
; ; ;
Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231
[No Abstract] [Full Text] [Related]
13. Atypical antipsychotics and diabetes mellitus.
Lichiardopol R
Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
[TBL] [Abstract][Full Text] [Related]
14. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
15. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome.
Shirzadi AA; Ghaemi SN
Harv Rev Psychiatry; 2006; 14(3):152-64. PubMed ID: 16787887
[TBL] [Abstract][Full Text] [Related]
16. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
17. Side effects of atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S
Curr Pharm Des; 2004; 10(18):2219-29. PubMed ID: 15281897
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotics and diabetes: an age-related association.
Hammerman A; Dreiher J; Klang SH; Munitz H; Cohen AD; Goldfracht M
Ann Pharmacother; 2008 Sep; 42(9):1316-22. PubMed ID: 18664607
[TBL] [Abstract][Full Text] [Related]
19. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
20. Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity.
Heal DJ; Gosden J; Jackson HC; Cheetham SC; Smith SL
Handb Exp Pharmacol; 2012; (212):135-64. PubMed ID: 23129331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]